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Lateral mass screw fixation in the cervical 
spine
To The ediTor: We read with interest the article by 
Kawabata et al.15 (Kawabata S, Watanabe K, Hosogane 
N, et al: Surgical correction of severe cervical kyphosis 
in patients with neurofibromatosis Type 1. Report of 3 
cases. J Neurosurg Spine 18:274–279, March 2013). Re-
constructive spinal surgery has undergone a tremendous 
transformation in the last several decades, with improve-
ments in imaging, biologics, and implant technologies. 
Not uncommonly, the spine surgical community may 
abandon an older technique when it becomes evident 
that a new approach or technology is clearly safer or su-
perior. Comparative clinical trials of older versus newer 
techniques are often limited to a small number of cases 
published over a short period of time and are typically 
not performed under the rigors of randomized controlled 
study sufficient to meet the standards set by governmental 
agencies to gain regulatory approval. Lateral mass screw 
fixation (LMSF) of the cervical spine, which has gener-
ally supplanted older wiring and hook cervical fixation 
methods, is one such technique. The article by Kawabata 
et al. published in this journal last year is a clear example 
of the use of cervical screw-rod fixation to treat complex 
deformity in a small series of patients with cervical ky-
phosis secondary to neurofibromatosis Type 1.15 The se-
verity of the deformity and the poor bone quality of the 
patients in this series would make any of the older fixation 
techniques clearly inadequate to maintain deformity cor-
rection and long-term stability.
Lateral mass screws have been implanted posteriorly 
in the cervical spine for nearly three-quarters of a centu-
ry.10 After first being reported in Europe by Roy-Camille 
in 1979, this technique of screw placement was modified 
by Magerl prior to its introduction in the United States in 
the 1980s.3,19,20 Initial systems consisted of simple bone 
screws placed through holes or slots in plates.13,19,20 This 
form of fixation has been studied extensively and found to 
be biomechanically superior to wiring techniques in vari-
ous unstable spinal fusion models.6,23,24 The Roy-Camille 
lateral mass screw–plate technique was introduced into 
the US by Paul Cooper, M.D. in the late 1980s, and the 
use of these systems in North America has grown steadily 
ever since.7,9 In the 1990s, second-generation plating sys-
tems emerged, which allowed more versatility in screw 
position through the plate holes. Despite this evolution in 
the implant design, several disadvantages of lateral mass 
screw plating systems persisted. These include anatomi-
cal restraints of the plating system with fixed hole–hole 
distances, a non-rigid connection of the screw to the plate, 
and the inability to compress or distract along the plate. 
Subsequent development of a screw-rod system solved 
these problems. Evolution of these LMSF systems oc-
curred based upon an increasing body of clinical evidence 
and experience.1,4,8,9,12,14,16,22,26 Despite this vast clinical ex-
perience, no system has been approved by the Food and 
Drug Administration (FDA) for “on label” usage in the 
subaxial cervical spine for the specific purpose of lateral 
mass fixation. Unfortunately this non-approval status con-
strains the ability of experienced spinal surgeons from ed-
ucating others regarding appropriate surgical indications, 
techniques, and practices.  
This non–FDA approval status of LMSF mirrors that 
of pedicle screw fixation in the thoracolumbar and lumbo-
sacral spine.10,28 The FDA denied the initial 510(k) appli-
cations for pedicle screws submitted in the mid-1980s and 
at the time was not convinced that there was a “pre-enact-
ment” product on which to base a substantially equivalent 
claim. The FDA did, however, grant a 510(k) clearance 
for the use of “bone screws” in the sacrum and anterior 
vertebral bodies of the spine. As of 1994, the FDA had 
not granted any manufacturer a 510(k) clearance or pre-
market approval (PMA) application for a bone screw indi-
cated for pedicle fixation. Spinal implant companies were 
thus prohibited from marketing screws for this indication 
and were prohibited from supporting educational activi-
ties surrounding its application.10 Similar to the current 
situation with lateral mass screws, this policy restricted 
a surgeon’s ability to teach pedicle screw implantation 
techniques, particularly under the auspices of corporate 
sponsorship from implant manufactures. This prevented 
corporate support of instructional courses sponsored by 
recognized academic spine societies including the Cervi-
cal Spine Research Society (CSRS), the North American 
Spine Society (NASS), the Scoliosis Research Society 
(SRS), American Association of Neurological Surgeons 
(AANS), and Congress of Neurological Surgeons (CNS). 
The International Meeting on Advanced Spine Techniques 
(IMAST) was initiated by the SRS in the early 1990s in 
order to support the free interchange of information on 
new spine technologies. All of the IMAST meetings to 
date have been outside of the US primarily to allow the 
discussion and teaching of newer technologies without 
the fear of reprisal from the FDA regarding promotion of 
“off-label” technologies.
To deal with this pedicle screw “dilemma,” a Sci-
entific Committee was formed to develop and oversee 
the “Historical Cohort Study of Pedicle Screw Fixation 
in Thoracic, Lumbar, and Sacral Spine Fusions.” The 
Scientific Committee consisted of representatives from 
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NASS, the American Academy of Orthopaedic Surgeons 
(AAOS), the SRS, the AANS, and the CNS, as well as a 
biostatistician and an industry representative. The Com-
mittee’s work was funded through a group of companies 
under the auspices of the Spinal Implant Manufacturers’ 
Group (SIMG), which had no control over the expendi-
tures, decisions regarding data acquisition, analysis, or re-
porting. Members of the FDA Office of Device Evaluation 
worked closely with the Scientific Committee and partici-
pated in all decisions. All data metrics were collected and 
validated by an independent biostatistician who assured 
the validity of the data and the accuracy of the data-pro-
cessing analyses while protecting confidentiality for the 
patients and physicians. This unified effort between the 
FDA, medical societies, and industry was unprecedented. 
A special meeting of the FDA Orthopaedic and Reha-
bilitation Devices Advisory Panel was held in Gaithers-
burg, Maryland in July 1994. Members of the Committee 
as well as other interested parties were allowed to speak 
over the course of this meeting. Following this meeting 
the Advisory Panel unanimously recommended to the 
FDA that pedicle screw devices be reclassified from Class 
III to Class II for the treatment of degenerative spondylo-
listhesis and fractures.10 This recommendation ultimately 
led to the full approval by the FDA for pedicle screw fixa-
tion devices for “conditions with significant mechanical 
instability or deformity of the thoracic, lumbar, and sacral 
spine secondary to degenerative spondylolisthesis with 
objective evidence of neurologic impairment, fracture, 
dislocation, scoliosis, kyphosis, spinal tumor, and failed 
previous fusion.”18
While similar, the situation with LMSF is not iden-
tical to the pedicle screw fixation dilemma. Despite the 
focus in the thoracolumbar spine, there has been little ef-
fort to pursue strategies to obtain “down-classification” 
of LMSF devices for the “on-label” use in the subaxial 
cervical spine. The CSRS, other professional societies, 
orthopedic surgeons, neurosurgeons, and representatives 
from industry believe that the time has come for change 
regarding the regulatory status of LMSF devices. At the 
Spring Board Meeting of the CSRS in April, 2011, then 
CSRS President Sanford Emery, M.D., tasked the CSRS 
Special Projects Committee with performing a system-
atic review and/or meta-analysis of the existing literature 
regarding LMSF with the ultimate goal of achieving “on-
label” classification for LMSF devises. This reclassifica-
tion would allow experienced cervical spinal surgeons 
the freedom to educate our colleagues in the performance 
of LMSF, which has become the standard of care for sta-
bilizing the cervical spine from a posterior approach for 
a variety of surgical indications. The CSRS Special Proj-
ects Committee asked that independent research organi-
zations be contracted to perform this project. The CSRS 
board agreed with the recommendation. After requests 
for proposals were sought, the Committee recommended 
that Spectrum Research, Incorporated (SRI), an indepen-
dent organization specializing in comparative-effective-
ness reviews, be contracted to conduct this study. This 
recommendation was ratified by the board with funding 
from the CSRS Research Fund to support the study. This 
study was thus completed under the direction of Joseph 
R. Dettori, M.P.H., Ph.D., of SRI with input from the 
Committee with regard to formulating the key questions 
and the PICO (patient, intervention, comparison, and out-
comes) tables. The results were tabulated by the research 
staff from SRI. The Committee provided further input 
to refine any significant but unaddressed questions. The 
final decision regarding the inclusion and exclusion of 
the comparative literature, however, was determined by a 
priori criteria and evaluated independently by 3 investiga-
tors. The Committee believes that the results of this effort 
are a truly unbiased look at the best available evidence 
regarding LMSF.5
The most feared direct complications of LMSF are in-
juries to the vertebral arteries and nerve roots. Screw pull-
out, implant disengagement, or fracture at the instrumented 
or adjacent segments are concerns, but they generally do 
not result in irreversible sequelae. The original lateral mass 
fixation technique as described by Roy-Camille involved 
a “straight ahead” trajectory in both the sagittal and axial 
planes,19 with a starting point directly in the center of the 
lateral mass. The technique was unicortical to minimize 
the risk of neurovascular injury. Over time, Roy-Camille 
modified the technique with a 10° lateral angulation in the 
axial plane in order to further avoid neurovascular injuries.7 
Magerl described a more lateral (20°–30°) angulation and 
a slightly more medial and cephalad starting point with his 
technique. Additionally, a more superiorly angulated sag-
ittal plane would maximize purchase, facilitate insertion, 
and further minimize the risk to the vertebral artery and 
nerve root.13 When these techniques were critically com-
pared in a cadaveric study, the Roy-Camille technique was 
typically more accurate with regard to zone of placement 
and possible nerve root risk than the Magerl technique.11 
Many others have since slightly modified the recommend-
ed insertion trajectory and starting points.2,3,26,27 While 
nerve root injuries and secondary radiculopathy are re-
ported with LMSF, most reports indicate resolution of any 
neurological deficit and pain with screw removal. Verte-
bral artery injury is extremely rare with lateral mass screw 
placement in the subaxial spine. 
This systematic review is not without significant limi-
tation. The papers included for review employ a variety of 
LMSF techniques for a variety of diagnoses with variable 
length of follow-up and variable outcome measures.5 Post-
operative CT scanning to evaluate screw placement ac-
curacy was not performed routinely.1,14,22 Stratification of 
complications in a manner meaningful to this review was 
challenging, with respect to comparison between papers 
and even stratification within papers. Furthermore, accept-
able comparative trials with different posterior fusion tech-
niques (wiring, clamps) were limited to only 2 studies.17,21 
Only one of these studies documented fusion rates.17 This 
sole comparative trial, however, supported the hypothesis 
that fusion rates are at least equivalent, if not superior to 
control (posterior wiring) methods of internal fixation.17 
Despite these limitations, there is sufficient information in 
the CSRS systematic review to gain reasonable insight into 
the safety and effectiveness of LMSF.5
The results of the CSRS study show that LMSF using 
modern implant systems is safe, with an acceptably low 
incidence of neurovascular injury. There is no evidence 
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from this review that the incidence of infections, hema-
tomas, deaths, or unspecified neurologic events is related 
to LMSF. Intuitively, the use of unicortical screw fixation 
would pose less risk to the neurovascular structures than 
bicortical fixation, at the cost of reduced screw purchase 
and increased incidence of screw failure. This study, how-
ever, was unable to establish evidence to support this hy-
pothesis, as the data in the reviewed papers either did not 
specify the technique employed or did not stratify screw 
failure as a function of cortical purchase. While compara-
tive data are relatively scant, it did not appear that LMSF 
techniques are any less or more effective than wire fixa-
tion techniques in achieving solid fusion.
On September 21, 2012, a meeting of the FDA’s Or-
thopaedic and Rehabilitation Devices Panel was held 
in Gaithersburg, Maryland.25 This meeting was held 
in response to a petition from the Orthopedic Surgical 
Manufacturers Association (OSMA) with testimony from 
OSMA presenters (Susan Krasny, Ph.D., member of the 
OSMA Board of Directors; John G. Heller, M.D.; Alex-
ander J. Ghanayem, M.D.; and Sharon Starowicz, OSMA 
president), FDA presenters (Caroline Rhim, Ph.D., Vin-
cent J. Devlin, M.D., and Genevieve Hill, B.S.) and 6 
open public hearing speakers testifying on behalf of 6 
professional societies and 1 research organization (Todd 
J. Albert, M.D., SRS; Paul A. Anderson, M.D., AAOS; 
William Welch, M.D., CNS and AANS; Gregory Przyb-
ylski, M.D., NASS; Lee H. Riley, M.D., CSRS; and Diana 
Zuckerman, Ph.D., National Research Center for Women 
and Families [NRCWF]).
Testimony began with a presentation by Susan Kras-
ny outlining the history and current status of FDA regula-
tion of pedicle screws. This was follow by a presentation 
from John Heller on the evolution and current status of 
LMSF techniques. He pointed out the lack of “equipoise” 
between LMSF and other fixation techniques in the pos-
terior cervical spine, which rendered the performance of 
a randomized controlled trial of LMSF in comparison to 
other techniques essentially impossible to perform. This 
was followed by Alexander Ghaneyem’s presentation 
of OSMA’s review of the published literature regarding 
the safety and effectiveness of cervical lateral mass and 
pedicle screws. The last section of the OSMA testimony 
was a presentation by Sharon Starowicz on the proposed 
regulatory controls for cervical screws.
The FDA representatives presented their own com-
prehensive review of cervical pedicle and lateral mass 
screws. They followed with a recommendation to down-
classify lateral mass and pedicle screws used in the cervi-
cal spine to Class II devices. It was noted that lateral mass 
screws were heretofore considered non-classified (that is, 
not Class III) devices, as there were no predicate devices 
prior to 1976. Not only did the FDA testimony accept the 
OSMA petition’s recommendation, they also expanded 
the recommendation to include pediatric age groups and 
include fixation to the upper thoracic spine and the use 
of screws in a variety of trajectories (C-2 pedicle, C-2 
pars interarticularis, C-2 and C-7 intralaminar, and C1–2 
trans articular). The use of posterior screws for limited 
non-fusion indications (tumors) was also recommended.
Testimony from CSRS, SRS, AAOS, AANS, CNS, 
and NASS was in support of down-classifying cervical 
lateral mass and pedicle screws to Class II devices. Lee 
Riley III formally presented the results of the CSRS sys-
tematic review, and these same data were presented in 
summary form by Todd Albert. The only unsupportive 
testimony in the open public hearing section was from 
Diane Zuckerman from the NRCWF who testified that 
randomized controlled trials of cervical screw systems 
should be performed before reclassification to the Class 
II category. She supported her testimony with data from a 
single recent Japanese study that noted a high complica-
tion rate with the use of cervical pedicle screws.
During the several question and answer periods (as 
well as the panel deliberations), a lively discussion was 
held on several points. One the questions concerned 
whether or not subaxial pedicle screws (C3–6) required 
special controls beyond that of lateral mass screws. An-
other question focused on the use of these devices in the 
pediatric population. Alvin H. Crawford, M.D., a pediat-
ric orthopedic surgeon and a non-voting panel member, 
noted the paucity of data regarding the use of cervical 
screw fixation in children but nevertheless felt that reclas-
sification was imperative in the pediatric population.  
Finally, after several hours of open deliberation with 
comments from the panel members including non-voting 
member surgeons, a patient representative, an industry 
representative, and a consumer representative, the FDA 
panel unanimously voted to accept the FDA proposal to 
classify cervical pedicle screws as Class II devices with 
the recommendation to identify C3–6 pedicle screw 
placement as a “more challenging technique” than lateral 
mass screw placement. They also followed the recom-
mendation that these devices were to be used as adjuncts 
to fusion only, with the limited exception of cases of ad-
vanced tumors where fixation could be achieved without 
mandating attempted fusion.
The next steps in reclassification will consist of a 
public posting of the proposed rule, marking the com-
mencement of a 90-day public comment period. After 
closure of the comment period, the final rule classify-
ing these devices will be issued. The time frame for this 
can be several months to several years. As of the writing 
of this letter, the public comment period has not yet be-
gun. Of note, if the final rule classifies posterior cervical 
screw-rod fixation systems as Class II, FDA approval for 
future similar systems will follow the 510(k) process.   
On the basis of this review, the CSRS Special Proj-
ects Review Committee does in fact believe that the 
data provide sufficient evidence for the FDA to consid-
er down-classification of lateral mass fixation screws to 
Class II devices for the treatment of unstable cervical 
fractures and fracture dislocation, the stabilization of the 
cervical spine rendered unstable by cervical laminec-
tomy, pseudarthrosis, and other indications. LMSF has 
become a standard technique in the armamentarium of 
most spine surgeons. Experienced and skilled spinal sur-
geons can use this technique safely to stabilize the cervi-
cal spine. The CSRS Special Projects Committee feels 
that it is imperative that these surgeons be given the abil-
ity to teach other less experienced surgeons LMSF tech-
niques in order to optimize patient care. We agree with 
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the even broader recommendations of the FDA panel for 
the down-classification of LMSF systems as well as other 
cervical spine screw systems as described above.  
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reSPonSe: We thank Dr. Coe and coauthors for re-
ferring to our work in their letter. We reported 3 cases 
of neurofibromatosis Type 1  presenting with severe cer-
vical kyphosis and dystrophic changes, which were suc-
cessfully managed by correction and fusion surgery. Re-
construction of severe cervical kyphosis in these cases 
posed tremendous technical challenges, particularly be-
cause the patients lacked osseous anchoring points for 
instrumentation due to severe dystrophic changes in lat-
eral masses, laminae, and pedicles. We placed screws at 
levels where the lateral masses and pedicles seemed to 
accept screw placement and were able to achieve good 
correction of severe kyphosis. Conventional hooks and 
sublaminar wires placed on the thin laminae might not 
have been effective. Thus, as illustrated in our cases, 
lateral mass and pedicle screws are often effective and 
sometimes indispensable for fusion surgery in cases of 
cervical spinal disorders accompanied by instability and 
deformity. 
We read with great interest Dr. Coe and colleagues’ 
description of their effort to have cervical lateral mass 
and pedicle screws down-classified to Class II devices. 
We believe that lateral mass and pedicle screws can ben-
efit patients with cervical spinal disorders if they are ap-




Please include this information when citing this paper: published 
online March 7, 2014; DOI: 10.3171/2013.11.SPINE13850.
©AANS, 2014
Tubular retractor selection in minimally 
invasive spinal tumor resection 
To The ediTor: We read with great interest the article 
by Nzokou et al.5 (Nzokou A, Weil AG, Shedid D: Mini-
mally invasive removal of thoracic and lumbar spinal 
tumors using a nonexpandable tubular retractor. Clinical 
article. J Neurosurg Spine 19:708–715, December 2013). 
There has been tremendous advancement in minimally 
invasive surgery (MIS) techniques and techologies over 
the past 15 years.6 Most spine surgeons today are familiar 
with MIS techniques, and many routinely perform MIS in 
their clinical practice to treat degenerative conditions of 
the spine. The application of MIS techniques in treating 
intradural spinal tumors was first reported by Tredway 
and colleagues7 in 2006. Since then, several other reports 
have further demonstrated the safety and efficacy of MIS 
techniques when using expandable tubular retractors in 
selected groups of patients with intra- or extradural spinal 
neoplasms.1–4 Nzokou et al. reported their experience in 
using 18-mm nonexpandable tubular retractors for spinal 
tumor resection in a series of 13 patients that included 4 
intradural cases. 
We applaud the excellent clinical results that the au-
thors obtained using MIS techniques to treat these less 
common spinal pathologies. However, we would like to 
point out several potential issues with using 18-mm non-
expandable tubular retractors in the resection of spinal 
tumors. First, a fundamental principle for any operative 
approach—minimally invasive or open surgery—is the 
ability to provide a satisfactory exposure and an adequate 
surgical corridor to reach the intended pathology. This 
is no different when dealing with spinal tumor resection 
during MIS. The selection of tubular retractor should be 
based on the size, location, and type of the lesion. The 
ideal tubular retractor should provide adequate exposure 
and working space while minimizing tissue trauma. The 
authors illustrated a case of T12–L1 intradural schwan-
noma in Fig. 3; although not mentioned, the tubular re-
tractor appears to be larger than 18 mm. The lack of full 
visualization of such an intradural tumor during resection 
may increase the risk of unnecessary retraction and ma-
nipulation of the tumor and, possibly, of the spinal cord 
if the lesion is located in the cervical or thoracic spine. 
Repositioning tubular retractors during tumor resection 
may also be hazardous to the patient, especially when 
treating intradural lesions with the spinal cord exposed. 
Second, restricted exposure typically results in intrale-
sional piecemeal tumor resection, which may be of little 
consequence when treating nerve sheath tumors but could 
